RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
XMAX
XMAX, Inc.
There isn't enough reported data to score XMAX yet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
XMAX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Unavailable | |
| Strong |
XMAX's revenue and balance sheet are currently healthy, and its profitability is stable. There isn't enough data to rate its cash flow.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
XMAX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 16x | $6.56 | — |
| Cheap | 17x | $6.78 | +3.4% |
| Fair | 21x | $8.62 | +31% |
| Expensive | 21x | $8.73 | +33% |
Historical ranges are pointers, not guarantees.
XMAX's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
XMAX Forward outlook
There aren't enough analyst estimates for XMAX to show an outlook.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
XMAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.41 | +$1.49 |
| Q1 2026 | -$0.14 | +$1.14 |
| Q4 2025 | -$0.17 | +$1.73 |
| Q3 2025 | -$0.42 | +$4.08 |
| Q2 2025 | -$1.08 | +$3.53 |
| Q1 2025 | -$1.28 | +$3.48 |
| Q4 2024 | -$1.90 | +$3.06 |
| Q3 2024 | -$4.50 | +$3.90 |
XMAX has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over XMAX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN has the edge over XMAX on profitability, with a higher operating margin.
XMAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.7M | +7.1% |
| Q1 2026 | $1.8M | -32% |
| Q4 2025 | $1.8M | -12% |
| Q3 2025 | $9.8M | +273% |
| Q2 2025 | $2.6M | -4.9% |
| Q1 2025 | $2.6M | +11% |
| Q4 2024 | $2M | -12% |
| Q3 2024 | $2.6M | +5.6% |
XMAX's revenue is growing: $3M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -44% | -37 points |
| Q1 2026 | -30% | -23 points |
| Q4 2025 | -59% | -11 points |
| Q3 2025 | -5% | +87 points |
| Q2 2025 | -7.7% | +11 points |
| Q1 2025 | -7.3% | +55 points |
| Q4 2024 | -48% | +119 points |
| Q3 2024 | -92% | -50 points |
XMAX's operating margin was −44% last quarter, down 37 points from the same quarter a year ago.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
XMAX has the stronger cash trend. Its trailing FCF is up 57% versus its history, compared with RIVN at down 2.1%.
XMAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$641.7K | -$319.1K |
| Q3 2025 | -$1.9M | -$1.5M |
| Q2 2025 | $92.5K | +$561.2K |
| Q1 2025 | -$322.6K | -$100.9K |
| Q4 2024 | -$263.4K | +$2.8M |
| Q1 2024 | -$221.7K | +$510.7K |
| Q4 2023 | -$3.1M | -$1.2M |
| Q1 2023 | -$732.4K | +$124.2K |
XMAX has burned cash in almost every quarter: −$3M over the past year, against −$1M the year before.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XMAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2019 | -1.0x | Net Cash |
| Q2 2019 | -4.5x | Net Cash |
XMAX has more cash than debt.
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
XMAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 30.6 | Neutral |
XMAX's weekly RSI is 41 (neutral) and its Stochastic is 31 (neutral).
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
XMAX PE vs Consumer Cyclical Sector
| Metric | XMAX | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
XMAX is trading at 16x earnings, a 11% discount to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
XMAX has stronger trend alignment. RIVN is above 0 of 5 weekly averages versus XMAX above 1 of 4.
XMAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.64 | 14% below |
| 20 week MA | $8.29 | 21% below |
| 50 week MA | $7.48 | 12% below |
| 100 week MA | $4.85 | 35% above |
XMAX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 35% above its 100-week average.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.
XMAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $3.77 | $3.77 | 0% |
| 2024 | $3.77 | $0.53 | -86% |
| 2025 | $0.53 | $6.00 | +1032% |
| 2026 YTD | $6.00 | $6.56 | +9.3% |
XMAX has the edge over RIVN on returns for 2026, with the stronger performance.